Glecaprevir

ATC J05AP57 · 9 markets · 20 records

Glecaprevir 9 markets · 20 records Forms

AU 5 records · 3 strengths

  • 100 mgtabletMaviret 100mg/40mg tabletsMAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack、MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet bottle also in GB·US·CA +1 unknown
  • 50 mgpowderMAVIRET glecaprevir 50 mg / pibrentasvir 20 mg granules sachet also in GB·CA unknown

Records without a stated strength · 1 Maviret 100mg/40mg tablets

GB 4 records · 2 strengths

US 2 records · 2 strengths

CA 2 records · 2 strengths

ES 2 records · 2 strengths

SG 1 records · 1 strengths

TW 1 records · 1 strengths

    Records without a stated strength · 1 Maviret 100mg/40mg tablets、艾百樂膜衣錠100毫克/40毫克

    HK 1 records · 1 strengths

      Records without a stated strength · 1 Maviret 100mg/40mg tablets

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        Records without a stated strength · 1 Maviret 100mg/40mg tablets

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.